Evidence map›Paper›PMID 38528930›Full record

ArticleRSC advances2024

Effect of CeO

Ryuku Maeda, Hiroshi Sampei, Reika Nakayama, Takuma Higo, Yoshiki Koshizuka, Yoshiro Bando, Tasuku Komanoya, Yunosuke Nakahara, Yasushi Sekine

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Low-temperature CORSC advances · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ryuku MaedaDepartment of Applied Chemistry, Waseda University 3-4-1, Okubo, Shinjuku 169-8555 Tokyo Japan ysekine@waseda.jp.
Hiroshi SampeiDepartment of Applied Chemistry, Waseda University 3-4-1, Okubo, Shinjuku 169-8555 Tokyo Japan ysekine@waseda.jp.ORCID https://orcid.org/0000-0001-5844-2977
Reika NakayamaDepartment of Applied Chemistry, Waseda University 3-4-1, Okubo, Shinjuku 169-8555 Tokyo Japan ysekine@waseda.jp.
Takuma HigoDepartment of Applied Chemistry, Waseda University 3-4-1, Okubo, Shinjuku 169-8555 Tokyo Japan ysekine@waseda.jp.ORCID https://orcid.org/0000-0002-2742-0836
Yoshiki KoshizukaDepartment of Applied Chemistry, Waseda University 3-4-1, Okubo, Shinjuku 169-8555 Tokyo Japan ysekine@waseda.jp.
Yoshiro BandoMitsui Mining and Smelting Co. Ltd 1333-2, Haraichi, Ageo 362-0021 Saitama Japan.
Tasuku KomanoyaMitsui Mining and Smelting Co. Ltd 1333-2, Haraichi, Ageo 362-0021 Saitama Japan.
Yunosuke NakaharaMitsui Mining and Smelting Co. Ltd 1333-2, Haraichi, Ageo 362-0021 Saitama Japan.
Yasushi SekineDepartment of Applied Chemistry, Waseda University 3-4-1, Okubo, Shinjuku 169-8555 Tokyo Japan ysekine@waseda.jp.ORCID https://orcid.org/0000-0001-6645-1961
Waseda University · JPMitsui Mining & Smelting (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ammonia is an extremely important storage and transport medium for renewable energy, and technology is expected to produce it on demand and onsite using renewable energy. Applying a DC (direct current) to a solid catalyst layer with semiconducting properties makes ammonia synthesis highly efficient, even at low temperatures (approximately 400 K). In this process, oxide supports with semiconducting properties play important roles as metal supports and conduction fields for electrons and protons. The influence of the degree of particle aggregation on the support properties and ammonia synthesis using an electric field was evaluated for CeO

Identifiers

PMID38528930
PMCPMC10962022
OpenAlexW4393147162

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.